Increasing Preference for OTC Solutions Strengthens Business Case
Independent Analysis of Annual Sales and Market Forecasts by Distribution Channel (Retail Pharmacies, Online Pharmacies, Other Distribution Channels), Route of Administration (Oral, Transdermal, Other Route of Administrations), and Treatment Type (Anticholinergic, Antihistamines, Other Treatment Types).
Motion Sickness Treatment Market
Dublin, Dec. 18, 2024 (GLOBE NEWSWIRE) — The “Motion Sickness Treatment – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
The global market for Motion Sickness Treatment was estimated at US$755.4 Million in 2023 and is projected to reach US$863.2 Million by 2030, growing at a CAGR of 1.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The report analyzes the Motion Sickness Treatment market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.
Segments
Distribution Channel (Retail Pharmacies, Online Pharmacies, Other Distribution Channels); Route of Administration (Oral, Transdermal, Other Route of Administrations); Treatment Type (Anticholinergic, Antihistamines, Other Treatment Types).
Geographic Regions/Countries Analyzed
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Report Features:
-
Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
-
Company Profiles: Coverage of major players in the Global Motion Sickness Treatment Market such as Baxter International, Inc., Caleb Pharmaceuticals, Inc., GlaxoSmithKline PLC, Myungmoon Pharma Co. Ltd., Perrigo Company PLC and more.
-
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
The growth in the motion sickness treatment market is driven by several factors, including increasing global travel, rising consumer awareness, and advancements in treatment options. One of the primary growth drivers is the increase in global tourism and business travel. As more people travel for leisure and work, the demand for effective motion sickness treatments has risen, especially for long-haul flights, cruises, and road trips. The rise of adventure tourism and activities like sailing, diving, and theme parks has further contributed to the demand for treatments that allow travelers to enjoy experiences without discomfort.
Growing consumer awareness and preference for preventive healthcare have also fueled demand for motion sickness treatments. With greater awareness of available treatments, consumers are proactively using medications, patches, and wearable devices before and during travel. Pharmacies, online retailers, and travel hubs have made these treatments more accessible, increasing adoption rates among frequent travelers, families, and those prone to motion sickness. The trend toward wellness-focused travel has encouraged people to carry motion sickness remedies as part of their travel essentials, further supporting market growth.
Advancements in medication formulations, wearable technologies, and non-pharmacological interventions have contributed to market expansion. Improved formulations of antihistamines, fast-acting oral solutions, and longer-lasting patches have made treatments more effective and convenient. Wearable devices that offer acupressure or neuromodulation provide drug-free alternatives, appealing to consumers who prefer natural or side-effect-free solutions. The rise of personalized medicine has also influenced the development of diverse treatment options, allowing users to choose treatments that best suit their needs and preferences.
Supportive government regulations and approvals have played a key role in expanding the motion sickness treatment market. Regulatory agencies have approved a variety of treatment options, including prescription medications, over-the-counter drugs, and medical devices, making it easier for manufacturers to introduce new products and reach broader consumer bases. Additionally, the growing use of telemedicine has facilitated greater access to prescription treatments for motion sickness, enabling more people to obtain appropriate medications before travel.
With ongoing innovations in treatment delivery, wearable technologies, and personalized healthcare solutions, the motion sickness treatment market is poised for continued growth. These trends, combined with increasing global travel, improved consumer awareness, and diverse treatment options, make motion sickness treatment a vital component of modern healthcare and travel strategies, ensuring comfort and well-being for travelers across different sectors.
Key Insights:
link
